PUBLISHED DATE : Aug 2022 | Pages : 298
Fill out your details & get your free sample
The Global Endoscope Reprocessing Market Research Report Includes Size in Terms of
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027
298 Pages
100 Tables
144 Charts
5 Regions
19 Countries
35 Companies
8 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2027) | USD 3.3 Billion |
| Market Size (2021) | USD 2.02 Billion |
| CAGR (2022-2027) | 8.37% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Product (Reprocessing Equipment, Disinfectants, Detergents, Drying, Storage & Transport Systems, Others), End User (Hospitals, Specialty Clinics & Medical Office Suites, Standalone Reprocessing Service Facilities, Others) |
| Geographic Analysis | North America, APAC, Europe, Latin America, and MEA |
| Key Vendors | Steris, Ecolab, Getinge AB, Olympus, Fortive |
The global endoscope reprocessing market was valued at USD 2.02 billion in 2021 and is expected to reach USD 3.3 billion by 2027, growing at a CAGR of 8.37% from 2022 to 2027. The global endoscope reprocessing market will likely witness incremental growth of over USD 1.2 billion and absolute growth of 62% during the forecast period. APAC is likely to be the fastest-growing region, with the highest CAGR of 9.60% during the forecast period. The region's main reason for fast growth is the growing availability of endoscope reprocessing systems, the presence of cheap labor, the low cost of manufacturing, and major technological advances in the healthcare sector.
Endoscope reprocessing is a multi-step process that involves effective cleaning, disinfection, and sterilization of endoscopy devices and their accessories. The high risk of infections associated with improper sterilization of endoscopes is majorly driving the demand for reprocessing equipment. The endoscope reprocessing market will flourish due to a focus on high cleaning standards and mounting pressures for sterilized and disinfected medical devices in hospitals and clinics.
The high usage of endoscopic devices mainly drives the global endoscope reprocessing market for diagnosis and treatment. This is due to the growing burden of various digestive and respiratory tract disorders that require endoscopy. Frequent use of these endoscopic instruments leads to an increased risk of infections; hence, these are being disinfected and cleaned using reprocessing systems. The demand for these systems is likely to grow in healthcare centers. Still, the high cost of endoscopy, improper or under-reprocessing leading to infections, and the growing prominence of single-use bio processors can hinder the market's growth.
Gastrointestinal (GI) endoscopy is essential for identifying and treating gastrointestinal tract disorders. Gastrointestinal endoscopes can become highly contaminated with their frequent use in patients, as millions of endoscopy procedures are being performed in the US alone. Cleaning, disinfection, and sterilization process are vital for the prevention of infections caused due to the contamination of these endoscopes. Hence the demand for reprocessing endoscopes has become highly important.
RISK OF GROWING TARGET POPULATION AND DEVELOPMENT OF ENDOSCOPIC INFECTIONS
The number of patients suffering from gastrointestinal diseases is rising across the world. These diseases are among the most costly and debilitating health conditions, accounting for about 3 million hospital admissions in the United States alone. The prevalence of these diseases is increasing the need for performing endoscopic procedures in various healthcare centers. An estimated 17 million lower GI endoscopies and about the same number of upper endoscopies are performed annually in the US. This initiates the risk of infections associated with the formation of biofilms due to their frequent usage. The infection rate approaches 1 in 10 million procedures. With the growing risk of these infections, the demand for endoscope reprocessing systems is growing.
THE GROWING TREND OF INCORPORATING TRACKING SOLUTIONS
Proper endoscope reprocessing is vital for patient safety. Ensuring that every step in the process is completed needs complex tracking and documentation. Eliminating manual documentation logs and ensuring the endoscope is disinfected and cleaned before using it in the procedure. Significant benefits of these tracking solutions include improved handling of endoscope complexity, integration with multiple systems, quality assurance of workflow, and optimization of return on investment.
TECHNOLOGICAL ADVANCEMENTS DRIVING MARKET GROWTH
Several manufacturers are emphasizing the automation of disinfection workflows to a large extent. This has also defined their production advancements and innovation strategies in recent years. For instance, in 2018, around $0.4 billion was invested in Olympus to enhance their systems for performing tests to check cleaning and disinfection effectiveness. Cleaning has always been challenging owing to the inability to inspect the cleanliness inside the lumens of an endoscope until now. The latest technological advancements have allowed the development of flexible inspection camera systems that can check an instrument's internal channels for debris and damage, which could help reduce infection rates.
HIGH COST OF ENDOSCOPY PROCEDURES AND REPROCESSING EQUIPMENT
The high cost associated with endoscopy lowers the number of endoscopic procedures performed on patients. Medical procedures such as endoscopies can be costly without insurance. The cost of a colonoscopy typically ranges between $1,250 to over $4,800 in the US, with an endoscopy's national average price of $2,750. Also, the equipment costs range from $114.07 to $280.71. The average reported repair cost—whether attributed to a leak test failure, damage during a visual inspection, or a failed cleaning verification test was estimated to be $5,833. Such high prices can limit the adoption of re-processing equipment.
IMPACT OF COVID-19 ON THE GLOBAL ENDOSCOPE REPROCESSING MARKET
Gastrointestinal complaints were frequent among COVID-19 patients, with possible occurrences of diarrhea, nausea, and vomiting. A March 2020 multicenter survey revealed near-universal exposure to COVID-19-positive patients in endoscopy units: 97.6% experienced a reduction in endoscopic activities, and 50% performed endoscopic procedures on COVID-19-positive patients. Hence, there was a moderate need for performing endoscopy procedures during COVID-19. Due to this, the demand for endoscope re-processing systems was high as there was a high risk of disease transmission among patients and healthcare providers.
PRODUCT
In 2021, disinfectants accounted for the largest share in the global endoscope reprocessing market. The demand for disinfectants is high as there is a growing need for disinfecting endoscopes. By equipment, the market is segmented as automated endoscope reprocessors and disinfection & sterilization equipment. Automated reprocessors accounted for the highest share in the market compared to disinfection & sterilization systems as the demand for automatic reprocessing systems is proliferating owing to their advanced features and better reprocessing.
END-USER
The end-user market includes hospitals, specialty clinics & medical office suites, standalone service facilities, and others. In 2021, hospitals accounted for the highest share of the global endoscopy device cleaning market. The use of endoscopic devices is high ins hospitals as these perform an increased number of endoscopic procedures compared to other healthcare settings. However, standalone reprocessing service facilities will likely witness the fastest growth during the forecast period.
GEOGRAPHY
In 2021, North America accounted for the highest share of the global endoscope reprocessing market. Significant factors contributing to the growth of the endoscope reprocessing market share in the North American region include a rise in the number of endoscopic procedures performed, high demand for sterilizing and disinfecting endoscopic devices, increasing prevalence of digestive disorders, guidelines promoting safe procedures, and technological advancements in the systems and accessories.
COMPETITIVE SCENARIO
The global market is highly competitive, with international, regional, and local players offering a broad range of products and accessories. Leading vendors such as STERIS, Ecolab, Getinge AB, Olympus, and ASP (acquired by Fortive) are coming up with several strategies such as partnerships, collaborations, joint ventures, mergers, and acquisitions for their growth and establishment in the industry.
For instance, STERIS recently agreed to acquire Cantel Medical, a global provider of infection prevention products and services primarily for endoscopy and dental customers.
Ecolab has developed vanBaerle, offering a full range of cleaning, disinfectant, and hygiene solutions, which can contribute to Ecolab's growth in cleaning and disinfectant products.
Product launches from these vendors are advancing the global endoscope reprocessing market. For instance, in 2020, Olympus launched its OER-Elite next-generation automated endoscope reprocessing system.
Frequently Asked Questions
How big is the global Endoscope Reprocessing Market?
The global endoscope reprocessing market is projected to grow at a CAGR of 8.37% reaching a market size of USD 3.3 billion in 2027 from USD 2.02 billion in 2021.
What are the key driving factors for the growth of the Endoscope Reprocessing Market?
Growing risk of developing endoscopy-related infections and increasing hospital investments in endoscopes & reprocessing systems will drive the industry growth.
Which region is anticipated to witness considerable growth in the endoscope reprocessing market?
The Asia-pacific region is expected to witness the fastest growth during the forecast period. However, the endoscope reprocessing market in North America will generate maximum revenue.
Which product is expected to hold the largest share in the endoscope reprocessing market?
In 2021, disinfectants accounted for the largest share in the global endoscope reprocessing market.
The global endoscope reprocessing market was valued at $2.02. billion in 2021 and is expected to reach $3.3 billion by 2027, growing at a CAGR of 8.37%.
The following factors are driving the global market growth.
Base Year: 2021
Forecast Year: 2022–2027
The study considers the global market’s present scenario and dynamics for 2022−2027. It covers a detailed overview of several growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Key Vendors:
Other Prominent Vendors
Market Segments
Product:
End-User
Geography
North America
Europe
APAC
Latin America
Middle East & Africa
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY END-USER
4.3.3 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 PREMIUM INSIGHTS
8.1 OVERVIEW
8.1.1 ENDOSCOPE REPROCESSING MARKET
8.1.2 ENDOSCOPE REPROCESSING: MARKET SEGMENTATIONS
8.1.3 COMPETITIVE SCENARIO
9 MARKET OPPORTUNITIES & TRENDS
9.1 INCREASED FDA EVALUATIONS & APPROVALS OF AUTOMATED ENDOSCOPE REPROCESSORS
9.2 DEMAND FOR ENDOSCOPE REPROCESSING TRACKING SOLUTIONS
9.3 TECHNOLOGICAL ADVANCES IN ENDOSCOPE REPROCESSING METHODS
10 MARKET GROWTH ENABLERS
10.1 INCREASE IN TARGET POPULATION REQUIRING ENDOSCOPIC INTERVENTIONS
10.2 RISK OF ENDOSCOPE-RELATED INFECTIONS
10.3 REGULATORY GUIDELINES THAT PROMOTE ENDOSCOPE REPROCESSING
10.4 HOSPITAL INVESTMENTS IN ENDOSCOPES & RELATED REPROCESSING SYSTEMS
11 MARKET RESTRAINTS
11.1 HIGH COST OF ENDOSCOPE REPROCESSING EQUIPMENT
11.2 SAFETY CONCERNS & LIMITATIONS OF ENDOSCOPE REPROCESSING
11.3 SIDE EFFECTS OF DETERGENTS & DISINFECTANTS
11.4 GROWTH IN POPULARITY OF SINGLE-USE ENDOSCOPES
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY PRODUCT
12.2.2 INSIGHTS BY ENDOSCOPE REPROCESSING EQUIPMENT
12.2.3 INSIGHTS BY END-USER
12.2.4 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 PRODUCT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
14 DISINFECTANTS
14.1 MARKET OVERVIEW
14.2 MARKET SIZE & FORECAST
14.2.1 DISINFECTANTS: MARKET BY GEOGRAPHY
15 REPROCESSING EQUIPMENT
15.1 MARKET OVERVIEW
15.2 MARKET SIZE & FORECAST
15.2.1 REPROCESSING EQUIPMENT: MARKET BY GEOGRAPHY
15.3 AUTOMATED ENDOSCOPE REPROCESSORS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 AUTOMATED ENDOSCOPE REPROCESSORS: MARKET BY GEOGRAPHY
15.4 DISINFECTION & STERILIZATION SYSTEMS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 DISINFECTION & STERILIZATION SYSTEMS: MARKET BY GEOGRAPHY
16 DETERGENTS
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.2.1 DETERGENTS: MARKET BY GEOGRAPHY
17 DRYING, STORAGE & TRANSPORT SYSTEMS
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.2.1 DRYING STORAGE, & TRANSPORT SYSTEMS: MARKET BY GEOGRAPHY
18 OTHERS
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 OTHERS: MARKET BY GEOGRAPHY
19 END-USER
19.1 MARKET SNAPSHOT & GROWTH ENGINE
19.2 MARKET OVERVIEW
19.3 HOSPITALS
19.3.1 MARKET OVERVIEW
19.3.2 MARKET SIZE & FORECAST
19.3.3 HOSPITALS: MARKET BY GEOGRAPHY
19.4 SPECIALTY CLINICS & MEDICAL OFFICE SUITES
19.4.1 MARKET OVERVIEW
19.4.2 MARKET SIZE & FORECAST
19.4.3 SPECIALTY CLINICS & MEDICAL OFFICE SUITES: MARKET BY GEOGRAPHY
19.5 STANDALONE REPROCESSING SERVICE FACILITIES
19.5.1 MARKET OVERVIEW
19.5.2 MARKET SIZE & FORECAST
19.5.3 STANDALONE REPROCESSING SERVICE FACILITIES: MARKET BY GEOGRAPHY
19.6 OTHERS
19.6.1 MARKET OVERVIEW
19.6.2 MARKET SIZE & FORECAST
19.6.3 OTHERS: MARKET BY GEOGRAPHY
20 GEOGRAPHY
20.1 MARKET SNAPSHOT & GROWTH ENGINE
20.2 GEOGRAPHIC OVERVIEW
21 NORTH AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 NORTH AMERICA: PRODUCT
21.2.2 NORTH AMERICA: REPROCESSING EQUIPMENT
21.2.4 NORTH AMERICA: END-USER
21.3 KEY COUNTRIES
21.3.1 US: MARKET SIZE & FORECAST
21.3.2 CANADA: MARKET SIZE & FORECAST
22 EUROPE
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.2.1 EUROPE: PRODUCT
22.2.2 EUROPE: REPROCESSING EQUIPMENT
22.2.4 EUROPE: END-USER
22.3 KEY COUNTRIES
22.3.1 GERMANY: MARKET SIZE & FORECAST
22.3.2 UK: MARKET SIZE & FORECAST
22.3.3 FRANCE: MARKET SIZE & FORECAST
22.3.4 ITALY: MARKET SIZE & FORECAST
22.3.5 SPAIN: MARKET SIZE & FORECAST
23 APAC
23.1 MARKET OVERVIEW
23.2 MARKET SIZE & FORECAST
23.2.1 APAC: PRODUCT
23.2.2 APAC: REPROCESSING EQUIPMENT
23.2.4 APAC: END-USER
23.3 KEY COUNTRIES
23.3.1 CHINA: MARKET SIZE & FORECAST
23.3.2 JAPAN: MARKET SIZE & FORECAST
23.3.3 INDIA: MARKET SIZE & FORECAST
23.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
23.3.5 AUSTRALIA: MARKET SIZE & FORECAST
24 LATIN AMERICA
24.1 MARKET OVERVIEW
24.2 MARKET SIZE & FORECAST
24.2.1 LATIN AMERICA: PRODUCT
24.2.2 LATIN AMERICA: REPROCESSING EQUIPMENT
24.2.4 LATIN AMERICA: END-USER
24.3 KEY COUNTRIES
24.3.1 BRAZIL: MARKET SIZE & FORECAST
24.3.2 MEXICO: MARKET SIZE & FORECAST
24.3.3 ARGENTINA: MARKET SIZE & FORECAST
25 MIDDLE EAST & AFRICA
25.1 MARKET OVERVIEW
25.2 MARKET SIZE & FORECAST
25.2.1 MIDDLE EAST & AFRICA: PRODUCT
25.2.2 MIDDLE EAST & AFRICA: REPROCESSING EQUIPMENT
25.2.4 MIDDLE EAST & AFRICA: END-USER
25.3 KEY COUNTRIES
25.3.1 TURKEY: MARKET SIZE & FORECAST
25.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
25.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
25.3.4 UAE: MARKET SIZE & FORECAST
26 COMPETITIVE LANDSCAPE
26.1 COMPETITION OVERVIEW
26.2 MARKET SHARE ANALYSIS
26.2.1 STERIS
26.2.2 ECOLAB
26.2.3 GETINGE
26.2.4 OLYMPUS
26.2.5 FORTIVE
27 KEY COMPANY PROFILES
27.1 STERIS
27.1.1 BUSINESS OVERVIEW
27.1.2 PRODUCT OFFERINGS
27.1.3 KEY STRATEGIES
27.1.4 KEY STRENGTHS
27.1.5 KEY OPPORTUNITIES
27.2 ECOLAB
27.2.1 BUSINESS OVERVIEW
27.2.2 PRODUCT OFFERINGS
27.2.3 KEY STRATEGIES
27.2.4 KEY STRENGTHS
27.2.5 KEY OPPORTUNITIES
27.3 GETINGE AB
27.3.1 BUSINESS OVERVIEW
27.3.2 PRODUCT OFFERINGS
27.3.3 KEY STRATEGIES
27.3.4 KEY STRENGTHS
27.3.5 KEY OPPORTUNITIES
27.4 OLYMPUS
27.4.1 BUSINESS OVERVIEW
27.4.2 PRODUCT OFFERINGS
27.4.3 KEY STRATEGIES
27.4.4 KEY STRENGTHS
27.4.5 KEY OPPORTUNITIES
27.5 FORTIVE
27.5.1 BUSINESS OVERVIEW
27.5.2 PRODUCT OFFERINGS
27.5.3 KEY STRATEGIES
27.5.4 KEY STRENGTHS
27.5.5 KEY OPPORTUNITIES
28 OTHER PROMINENT VENDORS
28.1 3M
28.1.1 BUSINESS OVERVIEW
28.1.2 PRODUCT OFFERINGS
28.2 ACURO ORGANICS LIMITED
28.2.1 BUSINESS OVERVIEW
28.2.2 PRODUCT OFFERINGS
28.3 ATMS
28.3.1 BUSINESS OVERVIEW
28.3.2 PRODUCT OFFERINGS
28.4 BECTO
28.4.1 BUSINESS OVERVIEW
28.4.2 PRODUCT OFFERINGS
28.5 BES HEALTHCARE
28.5.1 BUSINESS OVERVIEW
28.5.2 PRODUCT OFFERINGS
28.6 BRULIN
28.6.1 BUSINESS OVERVIEW
28.6.2 PRODUCT OFFERINGS
28.7 CARDINAL HEALTH
28.7.1 BUSINESS OVERVIEW
28.7.2 PRODUCT OFFERINGS
28.8 CENSIS
28.8.1 BUSINESS OVERVIEW
28.8.2 PRODUCT OFFERINGS
28.9 CETYLITE
28.9.1 BUSINESS OVERVIEW
28.9.2 PRODUCT OFFERINGS
28.10 CONMED
28.10.1 BUSINESS OVERVIEW
28.10.2 PRODUCT OFFERINGS
28.11 CONTEC
28.11.1 BUSINESS OVERVIEW
28.11.2 PRODUCT OFFERINGS
28.12 CREO MEDICAL
28.12.1 BUSINESS OVERVIEW
28.12.2 PRODUCT OFFERINGS
28.13 HAKO GROUP
28.13.1 BUSINESS OVERVIEW
28.13.2 PRODUCT OFFERINGS
28.14 HOYA
28.14.1 BUSINESS OVERVIEW
28.14.2 PRODUCT OFFERINGS
28.15 HYGIENE-KONZEPTE
28.15.1 BUSINESS OVERVIEW
28.15.2 PRODUCT OFFERINGS
28.16 LONZA
28.16.1 BUSINESS OVERVIEW
28.16.2 PRODUCT OFFERINGS
28.17 MEDALKAN
28.17.1 BUSINESS OVERVIEW
28.17.2 PRODUCT OFFERINGS
28.18 MEDICAL DEVICES GROUP SRL
28.18.1 BUSINESS OVERVIEW
28.18.2 PRODUCT OFFERINGS
28.19 METALL ZUG AG
28.19.1 BUSINESS OVERVIEW
28.19.2 PRODUCT OFFERINGS
28.20 METREX RESEARCH
28.20.1 BUSINESS OVERVIEW
28.20.2 PRODUCT OFFERINGS
28.21 MITRA GROUP
28.21.1 BUSINESS OVERVIEW
28.21.2 PRODUCT OFFERINGS
28.22 NANOSONICS
28.22.1 BUSINESS OVERVIEW
28.22.2 PRODUCT OFFERINGS
28.23 PENTAX MEDICAL
28.23.1 BUSINESS OVERVIEW
28.23.2 PRODUCT OFFERINGS
28.24 PHARMAX
28.24.1 BUSINESS OVERVIEW
28.24.2 PRODUCT OFFERINGS
28.25 PURPOSEBUILT BRANDS
28.25.1 BUSINESS OVERVIEW
28.25.2 PRODUCT OFFERINGS
28.26 RICHARD WOLF GMBH
28.26.1 BUSINESS OVERVIEW
28.26.2 PRODUCT OFFERINGS
28.27 SUMMIT IMAGING
28.27.1 BUSINESS OVERVIEW
28.27.2 PRODUCT OFFERINGS
28.28 SYMPLIANT
28.28.1 BUSINESS OVERVIEW
28.28.2 PRODUCT OFFERINGS
28.29 THE CLOROX COMPANY
28.29.1 BUSINESS OVERVIEW
28.29.2 PRODUCT OFFERINGS
28.30 TUTTNAUER
28.30.1 BUSINESS OVERVIEW
28.30.2 PRODUCT OFFERINGS
29 REPORT SUMMARY
29.1 KEY TAKEAWAYS
29.2 STRATEGIC RECOMMENDATIONS
30 QUANTITATIVE SUMMARY
30.1 MARKET BY PRODUCT
30.1.1 NORTH AMERICA: PRODUCT SEGMENTATION
30.1.2 EUROPE: PRODUCT SEGMENTATION
30.1.3 APAC: PRODUCT SEGMENTATION
30.1.4 LATIN AMERICA: PRODUCT SEGMENTATION
30.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
30.2 MARKET BY REPROCESSING EQUIPMENT
30.2.1 NORTH AMERICA: REPROCESSING EQUIPMENT SEGMENTATION
30.2.2 EUROPE: REPROCESSING EQUIPMENT SEGMENTATION
30.2.3 APAC: REPROCESSING EQUIPMENT SEGMENTATION
30.2.4 LATIN AMERICA: REPROCESSING EQUIPMENT SEGMENTATION
30.2.5 MIDDLE EAST & AFRICA: REPROCESSING EQUIPMENT SEGMENTATION
30.3 MARKET BY END-USER
30.3.1 NORTH AMERICA: END-USER SEGMENTATION
30.3.2 EUROPE: END-USER SEGMENTATION
30.3.3 APAC: END-USER SEGMENTATION
30.3.4 LATIN AMERICA: END-USER SEGMENTATION
30.3.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
30.4 MARKET BY GEOGRAPHY
30.4.1 DISINFECTANTS: GEOGRAPHY SEGMENTATION
30.4.2 REPROCESSING EQUIPMENT: GEOGRAPHY SEGMENTATION
30.4.3 DETERGENTS: GEOGRAPHY SEGMENTATION
30.4.4 DRYING, STORAGE, & TRANSPORT SYSTEMS: GEOGRAPHY SEGMENTATION
30.4.5 OTHERS: GEOGRAPHY SEGMENTATION
30.4.6 AUTOMATED ENDOSCOPE REPROCESSORS: GEOGRAPHY SEGMENTATION
30.4.7 DISINFECTION & STERILIZATION SYSTEMS: GEOGRAPHY SEGMENTATION
30.4.8 HOSPITALS: GEOGRAPHY SEGMENTATION
30.4.9 SPECIALTY CLINICS & MEDICAL OFFICE SUITES: GEOGRAPHY SEGMENTATION
30.4.10 STANDALONE REPROCESSING SERVICE FACILITIES: GEOGRAPHY SEGMENTATION
30.4.11 OTHERS: GEOGRAPHY SEGMENTATION
31 APPENDIX
31.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL ENDOSCOPE REPROCESSING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 SIMPLIFIED ILLUSTRATION OF ENDOSCOPE REPROCESSING CYCLE
EXHIBIT 4 DIFFERENT METHODS OF ENDOSCOPE REPROCESSING
EXHIBIT 5 MARKET DYNAMICS OF GLOBAL ENDOSCOPE REPROCESSING MARKET
EXHIBIT 6 SEGMENTATION OF GLOBAL ENDOSCOPE REPROCESSING MARKET
EXHIBIT 7 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY
EXHIBIT 8 IMPACT OF INCREASED FDA EVALUATIONS & APPROVALS OF AUTOMATED ENDOSCOPE REPROCESSORS
EXHIBIT 9 COMPLETED STATUS OF HLD OR LIQUID CHEMICAL STERILIZATION (LCS) VALIDATION TESTING OF AERS BY FDA
EXHIBIT 10 IMPACT OF DEMAND FOR ENDOSCOPE REPROCESSING TRACKING SOLUTIONS
EXHIBIT 11 MAJOR FEATURES OF ENDOSCOPE REPROCESSING TRACKING SOLUTIONS
EXHIBIT 12 IMPACT OF TECHNOLOGICAL ADVANCES IN ENDOSCOPE REPROCESSING METHODS
EXHIBIT 13 IMPACT OF INCREASE IN TARGET POPULATION REQUIRING ENDOSCOPIC INTERVENTIONS
EXHIBIT 14 IMPACT OF ENDOSCOPE-RELATED INFECTIONS
EXHIBIT 15 IMPACT OF REGULATORY GUIDELINES THAT PROMOTE ENDOSCOPE REPROCESSING
EXHIBIT 16 IMPACT OF HOSPITAL INVESTMENTS IN ENDOSCOPES & RELATED REPROCESSING SYSTEMS
EXHIBIT 17 IMPACT OF HIGH COST OF ENDOSCOPE REPROCESSING EQUIPMENT
EXHIBIT 18 IMPACT OF SAFETY CONCERNS & LIMITATIONS OF ENDOSCOPE REPROCESSING
EXHIBIT 19 IMPACT OF SIDE EFFECTS OF DETERGENTS & DISINFECTANTS
EXHIBIT 20 IMPACT OF GROWTH IN POPULARITY OF SINGLE-USE ENDOSCOPES
EXHIBIT 21 GLOBAL ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 22 GLOBAL ENDOSCOPE REPROCESSING MARKET BY PRODUCT
EXHIBIT 23 GLOBAL ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT
EXHIBIT 24 GLOBAL ENDOSCOPE REPROCESSING MARKET BY END-USER
EXHIBIT 25 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY
EXHIBIT 26 FIVE FORCES ANALYSIS 2021
EXHIBIT 27 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 28 GLOBAL ENDOSCOPE REPROCESSING MARKET BY PRODUCT
EXHIBIT 29 GLOBAL ENDOSCOPE REPROCESSING MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 30 GLOBAL ENDOSCOPE REPROCESSING MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 31 GLOBAL ENDOSCOPE REPROCESSING DISINFECTANTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 32 GLOBAL ENDOSCOPE REPROCESSING DISINFECTANTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 33 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 34 GLOBAL ENDOSCOPE REPROCESSING EQUIPMENT MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 35 GLOBAL ENDOSCOPE REPROCESSING EQUIPMENT MARKET 2021–2027 ($ MILLION)
EXHIBIT 36 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 37 GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET 2021–2027 ($ MILLION)
EXHIBIT 39 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 40 GLOBAL ENDOSCOPE REPROCESSING DISINFECTION & STERILIZATION SYSTEMS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 41 GLOBAL ENDOSCOPE REPROCESSING DISINFECTION & STERILIZATION SYSTEMS MARKET 2021–2027 ($ MILLION)
EXHIBIT 42 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 43 GLOBAL ENDOSCOPE REPROCESSING DETERGENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL ENDOSCOPE REPROCESSING DETERGENTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 45 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 46 GLOBAL ENDOSCOPE REPROCESSING DRYING, STORAGE, & TRANSPORT SYSTEMS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 47 GLOBAL ENDOSCOPE REPROCESSING DRYING, STORAGE, & TRANSPORT SYSTEMS MARKET 2021–2027 ($ MILLION)
EXHIBIT 48 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 49 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 50 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 51 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 52 INCREMENTAL GROWTH BY SEGMENT 2021 & 2027
EXHIBIT 53 GLOBAL ENDOSCOPE REPROCESSING MARKET BY END-USER
EXHIBIT 54 GLOBAL ENDOSCOPE REPROCESSING MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 55 GLOBAL ENDOSCOPE REPROCESSING MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL HOSPITALS ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 57 GLOBAL HOSPITALS ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 58 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 59 GLOBAL SPECIALTY CLINICS & MEDICAL OFFICE SUITES ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 60 GLOBAL SPECIALTY CLINICS & MEDICAL OFFICE SUITES ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 61 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 62 GLOBAL STANDALONE REPROCESSING SERVICE FACILITIES ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 63 GLOBAL STANDALONE REPROCESSING SERVICE FACILITIES ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 64 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 65 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 66 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 67 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 68 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 69 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY
EXHIBIT 70 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY: KEY COUNTRIES (2021)
EXHIBIT 71 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 72 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 73 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET: KEY COUNTRIES (2021)
EXHIBIT 74 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 75 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 76 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 77 INCREMENTAL GROWTH BY REPROCESSING EQUIPMENT 2021 & 2027
EXHIBIT 78 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 79 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 80 US ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 81 CANADA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 82 EUROPE ENDOSCOPE REPROCESSING MARKET: KEY COUNTRIES (2021)
EXHIBIT 83 EUROPE ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 84 EUROPE ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 85 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 86 INCREMENTAL GROWTH BY REPROCESSING EQUIPMENT 2021 & 2027
EXHIBIT 87 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 88 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 89 GERMANY ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 90 UK ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 91 FRANCE ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 92 ITALY ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 93 SPAIN ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 94 APAC ENDOSCOPE REPROCESSING MARKET: KEY COUNTRIES (2021)
EXHIBIT 95 APAC ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 96 APAC ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 97 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 98 INCREMENTAL GROWTH BY REPROCESSING EQUIPMENT 2021 & 2027
EXHIBIT 99 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 100 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 101 CHINA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 102 JAPAN ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 103 INDIA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 104 SOUTH KOREA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 105 AUSTRALIA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 106 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET: KEY COUNTRIES (2021)
EXHIBIT 107 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 108 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 109 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 110 INCREMENTAL GROWTH BY REPROCESSING EQUIPMENT 2021 & 2027
EXHIBIT 111 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 112 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 113 BRAZIL ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 114 MEXICO ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 115 ARGENTINA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 116 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET: KEY COUNTRIES (2021)
EXHIBIT 117 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 118 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 119 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 120 INCREMENTAL GROWTH BY REPROCESSING EQUIPMENT 2021 & 2027
EXHIBIT 121 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 122 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 123 TURKEY ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 124 SAUDI ARABIA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 125 SOUTH AFRICA ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 126 UAE ENDOSCOPE REPROCESSING MARKET 2021–2027 ($ MILLION)
EXHIBIT 127 PURE & DIVERSIFIED PLAYERS IN GLOBAL ENDOSCOPE REPROCESSING MARKET
EXHIBIT 128 POSITION OF MAJOR PLAYERS IN THE GLOBAL ENDOSCOPE REPROCESSING MARKET
EXHIBIT 129 GLOBAL ENDOSCOPE REPROCESSING MARKET: KEY VENDOR STRENGTHS & CAPABILITY ANALYSIS
EXHIBIT 130 STERIS: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 131 STERIS: REVENUE BY SEGMENT 2019–2021 ($ MILLION)
EXHIBIT 132 STERIS: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 133 STERIS: REVENUE BY GEOGRAPHY 2019–2021 ($ MILLION)
EXHIBIT 134 ECOLAB: TOTAL REVENUE 2018–2020 ($ MILLION)
EXHIBIT 135 ECOLAB: REVENUE BY SEGMENT 2018–2020 ($ MILLION)
EXHIBIT 136 ECOLAB: REVENUE BY R&D EXPENDITURE 2018–2020 ($ MILLION)
EXHIBIT 137 ECOLAB: REVENUE BY GEOGRAPHY (2020)
EXHIBIT 138 GETINGE AB: TOTAL REVENUE 2018–2020 ($ MILLION)
EXHIBIT 139 GETINGE AB: REVENUE BY GEOGRAPHY (2020)
EXHIBIT 140 OLYMPUS: REVENUE 2019–2021 ($ BILLION)
EXHIBIT 141 OLYMPUS: REVENUE SHARE BY DIVISION (2021)
EXHIBIT 142 : TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 143 : REVENUE BY SEGMENT 2019–2021 ($ MILLION)
EXHIBIT 144 : REVENUE BY R&D EXPENDITURE 2019–2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015–2021
TABLE 3 COMPARISON OF DIFFERENT AERS
TABLE 4 SPECIFIC RECOMMENDATIONS FOR REPROCESSING & STORAGE
TABLE 5 TOTAL ESTIMATED COST TO REPROCESS ONE ENDOSCOPE
TABLE 6 STERIS: MAJOR PRODUCT OFFERINGS
TABLE 7 ECOLAB: MAJOR PRODUCT OFFERINGS
TABLE 8 GETINGE: MAJOR PRODUCT OFFERINGS
TABLE 9 OLYMPUS: MAJOR PRODUCT OFFERINGS
TABLE 10 FORTIVE: MAJOR PRODUCT OFFERINGS
TABLE 11 3M: MAJOR PRODUCT OFFERINGS
TABLE 12 ACURO ORGANICS LIMITED: MAJOR PRODUCT OFFERINGS
TABLE 13 ATMS: MAJOR PRODUCT OFFERINGS
TABLE 14 BECTO: MAJOR PRODUCT OFFERINGS
TABLE 15 BES HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 16 BRULIN: MAJOR PRODUCT OFFERINGS
TABLE 17 CARDINAL HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 18 CENSIS: MAJOR PRODUCT OFFERINGS
TABLE 19 CETYLITE: MAJOR PRODUCT OFFERINGS
TABLE 20 CONMED: MAJOR PRODUCT OFFERINGS
TABLE 21 CONTEC: MAJOR PRODUCT OFFERINGS
TABLE 22 CREO MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 23 HAKO GROUP: MAJOR PRODUCT OFFERINGS
TABLE 24 HOYA: MAJOR PRODUCT OFFERINGS
TABLE 25 HYGIENE-KONZEPTE: MAJOR PRODUCT OFFERINGS
TABLE 26 LONZA: MAJOR PRODUCT OFFERINGS
TABLE 27 MEDALKAN: MAJOR PRODUCT OFFERINGS
TABLE 28 MEDICAL DEVICES GROUP SRL: MAJOR PRODUCT OFFERINGS
TABLE 29 METALL ZUG AG: MAJOR PRODUCT OFFERINGS
TABLE 30 METREX RESEARCH: MAJOR PRODUCT OFFERINGS
TABLE 31 MITRA GROUP: MAJOR PRODUCT OFFERINGS
TABLE 32 NANOSONICS: MAJOR PRODUCT OFFERINGS
TABLE 33 PENTAX MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 34 PHARMAX: MAJOR PRODUCT OFFERINGS
TABLE 35 PURPOSEBUILT BRANDS: MAJOR PRODUCT OFFERINGS
TABLE 36 RICHARD WOLF GMBH: MAJOR PRODUCT OFFERINGS
TABLE 37 SUMMIT IMAGING: MAJOR PRODUCT OFFERINGS
TABLE 38 SYMPLIANT: MAJOR PRODUCT OFFERINGS
TABLE 39 THE CLOROX COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 40 TUTTNAUER: MAJOR PRODUCT OFFERINGS
TABLE 41 GLOBAL ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 42 GLOBAL ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 (%)
TABLE 43 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 44 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 (%)
TABLE 45 EUROPE ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 46 EUROPE ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 (%)
TABLE 47 APAC ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 48 APAC ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 (%)
TABLE 49 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 50 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 (%)
TABLE 51 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 52 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET BY PRODUCT 2021–2027 (%)
TABLE 53 GLOBAL ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 ($ MILLION)
TABLE 54 GLOBAL ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 (%)
TABLE 55 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 ($ MILLION)
TABLE 56 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 (%)
TABLE 57 EUROPE ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 ($ MILLION)
TABLE 58 EUROPE ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 (%)
TABLE 59 APAC ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 ($ MILLION)
TABLE 60 APAC ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 (%)
TABLE 61 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 ($ MILLION)
TABLE 62 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 (%)
TABLE 63 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 ($ MILLION)
TABLE 64 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET BY REPROCESSING EQUIPMENT 2021–2027 (%)
TABLE 65 GLOBAL ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 66 GLOBAL ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 (%)
TABLE 67 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 68 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 (%)
TABLE 69 EUROPE ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 70 EUROPE ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 (%)
TABLE 71 APAC ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 72 APAC ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 (%)
TABLE 73 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 74 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 (%)
TABLE 75 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 76 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET BY END-USER 2021–2027 (%)
TABLE 77 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 78 GLOBAL ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 79 GLOBAL ENDOSCOPE REPROCESSING DISINFECTANTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 80 GLOBAL ENDOSCOPE REPROCESSING DISINFECTANTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 81 GLOBAL ENDOSCOPE REPROCESSING EQUIPMENT MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 82 GLOBAL ENDOSCOPE REPROCESSING EQUIPMENT MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 83 GLOBAL ENDOSCOPE REPROCESSING DETERGENTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 84 GLOBAL ENDOSCOPE REPROCESSING DETERGENTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 85 GLOBAL ENDOSCOPE REPROCESSING DRYING, STORAGE, & TRANSPORT SYSTEMS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 86 GLOBAL ENDOSCOPE REPROCESSING DRYING, STORAGE, & TRANSPORT SYSTEMS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 87 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 88 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 89 GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 90 GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 91 GLOBAL ENDOSCOPE REPROCESSING DISINFECTION & STERILIZATION SYSTEMS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 92 GLOBAL ENDOSCOPE REPROCESSING DISINFECTION & STERILIZATION SYSTEMS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 93 GLOBAL HOSPITALS ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 94 GLOBAL HOSPITALS ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 95 GLOBAL SPECIALTY CLINICS & MEDICAL OFFICE SUITES ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 96 GLOBAL SPECIALTY CLINICS & MEDICAL OFFICE SUITES ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 97 GLOBAL STANDALONE REPROCESSING SERVICE FACILITIES ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 98 GLOBAL STANDALONE REPROCESSING SERVICE FACILITIES ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 99 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 100 GLOBAL OTHERS ENDOSCOPE REPROCESSING MARKET BY GEOGRAPHY 2021–2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
